DUPIXENT was studied in the VENTURE trial, where 86% of patients reduced or eliminated their oral steroid dose with DUPIXENT 300 mg + Standard of Care (SOC) vs 68% with placebo + SOC.

Do not stop taking your corticosteroid medicines unless instructed by your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine to come back.

The most common side effects include injection site reactions, high count of a certain white blood cell (eosinophilia), and pain in the throat (oropharyngeal pain).

View the possible side effects of DUPIXENT in patients with moderate-to-severe eosinophilic or oral corticosteroid dependent asthma below.

View the possible side effects